KLK3 and Familial prostate cancer: Thus far, only one patient has developed a biochemical recurrence; he had high-risk prostate cancer (stage cT3a, Gleason score of 8, and pretreatment prostate-specific antigen level of 33) and refused hormone therapy as part of definitive treatment.